Literature DB >> 29572372

Parkinson's disease with hypocalcaemia: adult presentation of 22q11.2 deletion syndrome.

Fradique Moreira1, Ana Brás2, Joana Ramos Lopes2, Cristina Januário1.   

Abstract

A growing amount of evidence indicates that 22q11.2 deletion syndrome (22q11.2DS) increases the risk of early-onset Parkinson's disease (EOPD). Here, we describe a 36-year-old patient with EOPD. The patient presented with 22q11.2DS features, including associated cognitive disabilities, hypocalcaemia and facial dysmorphia that led us to screen for and confirm this deletion. In addition, hypocalcaemia and vitamin D deficiency were the main factors responsible for severe, painful muscle spasms that were non-levodopa (L-Dopa) responsive and remitted after calcium and vitamin D replacement therapy. Many patients with this deletion remain undiagnosed until adulthood due to the absence of 'major' phenotypic hallmarks, which usually present during early childhood. Later onset problems involving various medical subspecialties are increasingly recognised as important components of 22q11.2DS. Therefore, the multisystem nature and associated burden of morbidities demand a high degree of suspicion for this entity from all clinicians regardless of their medical subspecialty. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  calcium and bone; genetics; neurology; parkinson’s disease

Mesh:

Substances:

Year:  2018        PMID: 29572372      PMCID: PMC5878318          DOI: 10.1136/bcr-2017-223751

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Early-onset Parkinson disease leading to diagnosis of 22q11.2 deletion syndrome.

Authors:  Rebecca Pollard; Markus Hannan; Jody Tanabe; Brian D Berman
Journal:  Parkinsonism Relat Disord       Date:  2016-02-03       Impact factor: 4.891

2.  22q11.2 deletion syndrome presenting with early-onset Parkinson's disease.

Authors:  Aliya F Rehman; Radhika Dhamija; Eli S Williams; Matthew J Barrett
Journal:  Mov Disord       Date:  2015-07-21       Impact factor: 10.338

3.  Large 3-Mb deletions at 22q11.2 locus in Parkinson's disease and schizophrenia.

Authors:  Jia Nee Foo; Jimmy Lee; Louis C Tan; Jianjun Liu; Eng-King Tan
Journal:  Mov Disord       Date:  2016-10-27       Impact factor: 10.338

4.  Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.

Authors:  Nancy J Butcher; Tim-Rasmus Kiehl; Lili-Naz Hazrati; Eva W C Chow; Ekaterina Rogaeva; Anthony E Lang; Anne S Bassett
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

Review 5.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

6.  Vitamin D deficiency, behavioral atypicality, anxiety and depression in children with chromosome 22q11.2 deletion syndrome.

Authors:  L Kelley; A F P Sanders; E A Beaton
Journal:  J Dev Orig Health Dis       Date:  2016-12       Impact factor: 2.401

Review 7.  Endocrine aspects of the 22q11.2 deletion syndrome.

Authors:  S A Weinzimer
Journal:  Genet Med       Date:  2001 Jan-Feb       Impact factor: 8.822

Review 8.  Practical guidelines for managing adults with 22q11.2 deletion syndrome.

Authors:  Wai Lun Alan Fung; Nancy J Butcher; Gregory Costain; Danielle M Andrade; Erik Boot; Eva W C Chow; Brian Chung; Cheryl Cytrynbaum; Hanna Faghfoury; Leona Fishman; Sixto García-Miñaúr; Susan George; Anthony E Lang; Gabriela Repetto; Andrea Shugar; Candice Silversides; Ann Swillen; Therese van Amelsvoort; Donna M McDonald-McGinn; Anne S Bassett
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

9.  Prevalence of hypocalcaemia and its associated features in 22q11·2 deletion syndrome.

Authors:  Evelyn Ning Man Cheung; Susan R George; Gary A Costain; Danielle M Andrade; Eva W C Chow; Candice K Silversides; Anne S Bassett
Journal:  Clin Endocrinol (Oxf)       Date:  2014-05-27       Impact factor: 3.478

10.  Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.

Authors:  Kin Y Mok; Una Sheerin; Javier Simón-Sánchez; Afnan Salaka; Lucy Chester; Valentina Escott-Price; Kiran Mantripragada; Karen M Doherty; Alastair J Noyce; Niccolo E Mencacci; Steven J Lubbe; Caroline H Williams-Gray; Roger A Barker; Karin D van Dijk; Henk W Berendse; Peter Heutink; Jean-Christophe Corvol; Florence Cormier; Suzanne Lesage; Alexis Brice; Kathrin Brockmann; Claudia Schulte; Thomas Gasser; Thomas Foltynie; Patricia Limousin; Karen E Morrison; Carl E Clarke; Stephen Sawcer; Tom T Warner; Andrew J Lees; Huw R Morris; Mike A Nalls; Andrew B Singleton; John Hardy; Andrey Y Abramov; Vincent Plagnol; Nigel M Williams; Nicholas W Wood
Journal:  Lancet Neurol       Date:  2016-03-24       Impact factor: 59.935

View more
  1 in total

Review 1.  22q11.2 Deletion Syndrome-Associated Parkinson's Disease.

Authors:  Erik Boot; Anne S Bassett; Connie Marras
Journal:  Mov Disord Clin Pract       Date:  2018-11-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.